Brand name drug manufacturer discounts used to reduce cost sharing charged to enrollees [Sec. 2922, 2956, 9323 (2)] -
SB111Clinician-administered drugs: certain practices prohibited re state’s insurance unfair marketing and trade practices law -
AB718Clinician-administered drugs: certain practices prohibited re state’s insurance unfair marketing and trade practices law -
SB753Copayment for prescription drugs under MA eliminated [Sec. 1017-1020] [original bill only] -
AB68Copayment for prescription drugs under MA eliminated [Sec. 1017-1020] -
SB111Cost sharing payments for prescription drugs under MA eliminated -
AB559Cost sharing payments for prescription drugs under MA eliminated -
SB552DHS to reimburse ambulance service providers for replacement sets of epinephrine auto-injectors or kits under certain conditions; pharmacist may substitute a drug product prescribed to counteract anaphylaxis under set conditions; UW System, TCS, and special education aid funding from certain federal aid -
AB740DHS to reimburse ambulance service providers for replacement sets of epinephrine auto-injectors or kits under certain conditions; pharmacist may substitute a drug product prescribed to counteract anaphylaxis under set conditions; UW System, TCS, and special education aid funding from certain federal aid -
SB706Drug and alcohol testing following officer-involved critical incidents: law enforcement agencies required to adopt written policy -
AB334Drug and alcohol testing following officer-involved critical incidents: law enforcement agencies required to adopt written policy -
SB476Drug Evaluation and Classification Program in DOT: funding provision -
AB1141Epinephrine prefilled syringes: authorities for prescription, possession, and administration of epinephrine auto-injectors expanded to include; statewide standing order provision -
AB337Epinephrine prefilled syringes: authorities for prescription, possession, and administration of epinephrine auto-injectors expanded to include; statewide standing order provision -
SB343Federal drug pricing program (340B program) participants: reimbursing certain entities and imposing a fee or other adjustment prohibited -
AB550Federal drug pricing program (340B program) participants: reimbursing certain entities and imposing a fee or other adjustment prohibited [Sec. 2969] [original bill only] -
AB68Federal drug pricing program (340B program) participants: reimbursing certain entities and imposing a fee or other adjustment prohibited [Sec. 2969] -
SB111Federal drug pricing program (340B program) participants: reimbursing certain entities and imposing a fee or other adjustment prohibited -
SB542Hospitals participating in federal drug pricing program (340B program): prescription drug cost reporting [Sec. 2966] [original bill only] -
AB68Hospitals participating in federal drug pricing program (340B program): prescription drug cost reporting [Sec. 2966] -
SB111Insulin: cost sharing under health insurance policies and plans capped -
AB552Insulin: cost sharing under health insurance policies and plans capped -
SB546Insulin cost-sharing cap imposed [Sec. 2923, 2972-2974, 9423 (2)] [original bill only] -
AB68Insulin cost-sharing cap imposed [Sec. 2923, 2972-2974, 9423 (2)] -
SB111Insulin safety net programs created -
AB557Insulin safety net programs created [Sec. 2968] [original bill only] -
AB68Insulin safety net programs created [Sec. 2968] -
SB111Insulin safety net programs created -
SB553Kratom products made from the leaf of the Mitragyna speciosa plant: manufacture, distribution, delivery, and possession regulated -
AB599Kratom products made from the leaf of the Mitragyna speciosa plant: manufacture, distribution, delivery, and possession regulated -
SB958Medical aid in dying provisions created; JRCCP may report -
AB1078Medical aid in dying provisions created; JRCCP may report -
SB1013Medical marijuana program created, license provisions; Medical Marijuana Regulatory Commission created and attached to DOR; excise tax, criminal provisions, Prescription Drug Monitoring Program, fair employment law, UI, and WC provisions; JRCCP may report -
AB1067Medical marijuana program created, license provisions; Medical Marijuana Regulatory Commission created and attached to DOR; excise tax, criminal provisions, Prescription Drug Monitoring Program, fair employment law, UI, and WC provisions; JRCCP may report -
SB1034Medication-assisted treatment for substance use grants expansion -
AB845Medication-assisted treatment for substance use grants expansion -
SB1033Medication-assisted treatment grants re opioid dependence [Sec. 782] [original bill only] -
AB68Medication-assisted treatment grants re opioid dependence [Sec. 782] -
SB111Multidistrict opiate litigation settlement: AG to cooperate with local governments; conditions specified -
AB374Multidistrict opiate litigation settlement: AG to cooperate with local governments; conditions specified -
SB386Off-label therapies: access to by terminally ill patients -
AB979Opioid and methamphetamine data system: DOA to administer contract with vendor and collaborate with other departments; report required [Sec. 2288, 9101 (3)] [original bill only] -
AB68Opioid and methamphetamine data system: DOA to administer contract with vendor and collaborate with other departments; report required [Sec. 2288, 9101 (3)] -
SB111Opioid and methamphetamine data system: DOA to establish, collect data from other departments, and submit report to JCF -
AB41Opioid and methamphetamine data system: DOA to establish, collect data from other departments, and submit report to JCF [S.Amdt.2: appropriation removed] -
SB49Opioid and methamphetamine data system established; data collected from certain departments, report to JCF required -
AB444Opioid and methamphetamine data system established; data collected from certain departments, report to JCF required -
SB439Patient pharmacy benefit tool re cost of prescription drugs: grants to develop and implement [Sec. 2910] [original bill only] -
AB68Patient pharmacy benefit tool re cost of prescription drugs: grants to develop and implement [Sec. 2910] -
SB111Patient pharmacy benefit tool re cost of prescription drugs: grants to develop and implement; special education, UW System, and TCS funding provision -
AB549Patient pharmacy benefit tool re cost of prescription drugs: grants to develop and implement -
SB554Pharmacist training on dispensing opioid antagonists required [Sec. 2879, 2882, 9138 (2)] [original bill only] -
AB68Pharmacist training on dispensing opioid antagonists required [Sec. 2879, 2882, 9138 (2)] -
SB111Pharmacists authorized to extend a prescription order: 2019 WisAct 185 provisions extended -
AB1Pharmacists authorized to extend a prescription order: 2020 public health emergency provision extended -
SB149Pharmacists authorized to extend a prescription order, expires December 31, 2021 -
AB31Pharmacy benefit manager license and regulation requirements; pharmacy requirements re drug substitution, listing of retail prices and generic and corresponding brand name drugs, and notification of changes to prescription benefits [Sec. 730, 733, 734, 1117, 2163, 2397, 2885-2887, 2906, 2911, 2924, 2926, 2954, 2955, 2959-2963, 2965, 2987-3009, 9123 (1), 9323 (1), 9423 (1)] [original bill only] -
AB68Pharmacy benefit manager license and regulation requirements; pharmacy requirements re drug substitution, listing of retail prices and generic and corresponding brand name drugs, and notification of changes to prescription benefits [Sec. 730, 733, 734, 1117, 2163, 2397, 2885-2887, 2906, 2911, 2924, 2926, 2954, 2955, 2959-2963, 2965, 2987-3009, 9123 (1), 9323 (1), 9423 (1)] -
SB111Pharmacy benefit manager licensure requirements and regulations; cost-sharing limitation; specified disclosures to customers; notification of drug substitution -
AB7Pharmacy benefit manager licensure requirements and regulations; cost-sharing limitation; specified disclosures to customers; notification of drug substitution -
SB3Pharmacy technicians authorized to administer vaccines; any health care provider authorized to administer vaccines may supervise pharmacy students administering vaccines [A.Amdt.1: adds administration of specified drugs for adverse reactions; S.Amdt.1: adds use of the title “pharmacist” provision] -
AB4Prescription Drug Affordability, Office of, in the OCI: funding for establishment of and FTE positions -
AB556Prescription Drug Affordability, Office of, in the OCI: funding for establishment of and FTE positions -
SB578Prescription Drug Affordability Review Board created -
AB544Prescription Drug Affordability Review Board created [Sec. 67, 88, 2914-2917, 9123 (8), 9423 (4)] [original bill only] -
AB68Prescription Drug Affordability Review Board created [Sec. 67, 88, 2914-2917, 9123 (8), 9423 (4)] -
SB111Prescription Drug Affordability Review Board created -
SB540Prescription drug cost reporting by manufacturers: requirements established -
AB512Prescription drug cost reporting by manufacturers: requirements established -
SB499Prescription drug cost reporting requirements [Sec. 2953, 2967, 9123 (3)] [original bill only] -
AB68Prescription drug cost reporting requirements [Sec. 2953, 2967, 9123 (3)] -
SB111Prescription drug importation program established [Sec. 2912, 9123 (2)] [original bill only] -
AB68Prescription drug importation program established; JCF approval required -
AB548Prescription drug importation program established [Sec. 2912, 9123 (2)] -
SB111Prescription drug importation program established; JCF approval required -
SB539Prescription drug limits prohibition enacted in 2019 WisAct 185 reinstated -
AB1Prescription drug limits prohibition enacted in 2019 WisAct 185 reinstated, period specified -
AB31Prescription drug limits prohibition enacted in 2019 WisAct 185 reinstated, period specified -
SB130Prescription Drug Monitoring Program: certain exemption to review of patient’s records repealed -
AB430Prescription Drug Monitoring Program: certain exemption to review of patient’s records repealed -
SB407Prescription drug payments made by enrollee applied to health insurance out-of-pocket maximum or cost-sharing requirements -
AB184Prescription drug payments made by enrollee applied to health insurance out-of-pocket maximum or cost-sharing requirements -
SB215Reckless handling of a vaccine or drug rendering it ineffective or unusable made a felony; JRCCP may report -
AB225Reckless handling of a vaccine or drug rendering it ineffective or unusable made a felony; JRCCP may report [S.Amdt.1: "reckless handling" changed to "intentional destruction"] -
SB242State prescription drug purchasing entity study -
AB558State prescription drug purchasing entity study [Sec. 9123 (6)] -
SB111State prescription drug purchasing entity study [Sec. 9123 (6)] [original bill only] -
AB68State prescription drug purchasing entity study -
SB551Step therapy protocol for certain cancer drugs: insurer, pharmacy benefit manager, or utilization review organization prohibited from requiring -
AB745
